Jiann-Jy Chen, Yen-Wen Chen, Bing-Yan Zeng, Chao-Ming Hung, Bing-Syuan Zeng, Brendon Stubbs, Andre F Carvalho, Trevor Thompson, Michael Roerecke, Kuan-Pin Su, Yu-Kang Tu, Yi-Cheng Wu, Lee Smith, Tien-Yu Chen, Pao-Yen Lin, Chih-Sung Liang, Chih-Wei Hsu, Shih-Pin Hsu, Hung-Chang Kuo, Ming-Kung Wu, Ping-Tao Tseng
BACKGROUND: Although tinnitus has a prevalence between 20 and 42.8%, the currently recommended management for tinnitus, such as tinnitus support and psychologic therapies, are relatively time-consuming and expensive. Several new pharmacologic treatments designed for tinnitus patients without specific origin had been developed but their efficacy remains unclear. METHODS: The current Network Meta-Analysis (NMA) of randomised controlled trials (RCTs) was conducted to evaluate the efficacy of different pharmacologic treatments for tinnitus management in tinnitus patients without specific or treatable origin (i...
September 2021: EClinicalMedicine